Mechanistically, we found that CDCA5 promoted the binding of E2F transcription factor 1 (E2F1) to FOXM1 promoter, and Wnt/β-catenin signaling was required for CDCA5 induced development of breast cancer. Here, E2F1 is linked to breast cancer.